Evaluation of Biofield Modality on Viral Load of Hepatitis B and C Viruses
Mahendra Kumar Trivedi



Support
Academic Torrents!

Disable your
ad-blocker!

Evaluation of Biofield Modality on Viral Load of Hepatitis B and C Viruses.pdf581.65kB
Type: Paper
Tags: Biofield treatment, Trivedi Effect, Biofield, Mahendra Kumar Trivedi, Biofield Energy Treatment, Viral Load, Hepatitis B virus, Hepatitis C virus, HBV DNA, HCV RNA, Hep C Viral Load, HCV RNA Viral Load, Hepatitis B Viral Load Test, Cobas Amplicor HCV Monitor Test, HCV RNA Viral Load Test

Bibtex:
@article{,
title= {Evaluation of Biofield Modality on Viral Load of Hepatitis B and C Viruses},
keywords= {Biofield, Trivedi Effect, Mahendra Kumar Trivedi, Biofield Treatment, Biofield Energy Treatment, Viral Load, Hepatitis B virus, Hepatitis C virus, HBV DNA, HCV RNA, Hep C Viral Load, HCV RNA Viral Load, Hepatitis B Viral Load Test, Cobas Amplicor HCV Monitor Test, HCV RNA Viral Load Test},
journal= {Antivirals & Antiretrovirals},
author= {Mahendra Kumar Trivedi},
year= {2015},
url= {https://www.trivedieffect.com/the-science/publications/microbiology-publications/evaluation-of-biofield-modality-on-viral-load-of-hepatitis-b-and-c-viruses/
},
license= {Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International},
abstract= {Study background: Nowadays, hepatitis is a major challenge for clinical research, regulatory bodies, and clinicians who are trying to assess the more effectiveness of antiviral therapy against patients. Viral load count is the amount of particular viral DNA or RNA in a blood samples. It is one of the surrogate biomarker of hepatitis. High viral load indicates that the immune system is failed to fight against viruses. The aim of this study was to evaluate the impact of biofield modality on hepatitis B virus (HBV) and hepatitis C virus (HCV) in terms of viral load as surrogate marker.

Method: The viral load assay was performed on stock human plasma samples of HBV and HCV before and after 7 days of biofield treatment using Roche COBAS® AMPLICOR analyzer according to manufacturer’s instructions. Viremia (viral DNA for HBV, RNA for HCV) was considered as surrogate marker for assessment of the impact of Mr. Trivedi’s biofield treatment.

Result: The viral load of HBV DNA in infected plasma samples showed a significant alteration in the biofield treated group as compared to control. Additionally, viral load count of HCV RNA in infected plasma samples was significantly reduced by 67% in the biofield treated group as compared to control. As the biofield treatment has significantly reduced HCV RNA, it could be beneficial for particularly HCV infected populations.

Conclusion: Altogether, data suggest that biofield treatment has significantly alteration in HBV and reduced the viral load count in HCV infected plasma samples and could be a suitable alternative treatment strategy for hepatitis patients in near future.},
superseded= {},
terms= {}
}